Company intelligence / Profile preview

Systems Oncology

Scottsdale, Arizona, United Statessystemsoncology.com ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Systems Oncology is developing multiple cancer therapeutic programs, including a promising breast cancer drug preparing to enter clinical trials and a novel drug licensed to Toray projected to be effective across many cancer indications[3]

Therapeutic areas: Oncology
Modalities: Multimodal RNA therapeutics
Industry: Biotech

Drug pipeline

1 asset

DIM-C

Preclinical

Partnerships

Toray (Japanese company)Texas A&Mnegotiations with "one of the top pharmaceutical companies"[3][4]

Beyond the preview

Go deeper on Systems Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systems Oncology.

Explore the full profile